Because patients with IBC are at high risk of recurrence and metastatic disease41 and because IBC tumors are stem cell-enriched12, we further investigated the effect of DCN overexpression on cell migration and invasion as well as cancer stem cell features. This evidence concerns the gene DCN and inflammatory breast carcinoma.